Abel Hannah, Kephart George, Packer Tanya, Warner Grace
Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.
Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.
Value Health. 2017 Sep;20(8):1157-1165. doi: 10.1016/j.jval.2017.04.008. Epub 2017 Jun 7.
To examine the extent of disagreement in estimated utility between the six-dimensional health state short form (SF-6D) and the Health Utilities Index-Mark 3 (HUI3) in Canadians with neurological conditions and how discordance varied by participant and neurological condition attributes.
The study analyzed cross-sectional survey data from the Living with and Managing the Impact of a Neurological Condition Study. Self-reported data were collected on the burden and impact of neurological conditions on participants' everyday lives. Disagreement was examined by comparing utility distributions, paired t tests of the means, Spearman ρ correlations, intraclass correlations, and Bland-Altman plots. Associations between participant and neurological condition attributes and utility differences were assessed using multiple regression models.
Disagreement between the SF-6D and the HUI3 was substantial, with a mean utility difference of 0.15 (95% confidence interval 0.13-0.17). An intraclass correlation coefficient of 0.41 suggests only marginal agreement. The Bland-Altman plot and regression analysis showed systematic variation in utility difference associated with level of utility. Depending on the level of utility, utility differences between the SF-6D and the HUI3 shift in magnitude and direction. The pattern of disagreement did not vary substantially by participant or neurological condition characteristics.
The SF-6D and the HUI3 provide inconsistent evaluations of utility in persons with neurological conditions. The magnitude and direction of differences in estimated utility are strongly associated with level of utility. Depending on the health status of the sample, the SF-6D and the HUI3 could provide widely contradictory utility estimates. A concern is that utility scores, and hence potential evaluations and health care decisions, may vary simply according to the choice of instrument.
探讨六维健康状态简表(SF - 6D)与健康效用指数 - 第3版(HUI3)在患有神经系统疾病的加拿大人中效用估计的不一致程度,以及不一致性如何因参与者和神经系统疾病属性而异。
该研究分析了来自神经系统疾病的生活与管理影响研究的横断面调查数据。收集了关于神经系统疾病对参与者日常生活的负担和影响的自我报告数据。通过比较效用分布、均值的配对t检验、Spearman ρ相关性、组内相关性和Bland - Altman图来检查不一致性。使用多元回归模型评估参与者和神经系统疾病属性与效用差异之间的关联。
SF - 6D与HUI3之间的不一致性很大,平均效用差异为0.15(95%置信区间0.13 - 0.17)。组内相关系数为0.41表明仅有边际一致性。Bland - Altman图和回归分析显示效用差异与效用水平存在系统变化。根据效用水平,SF - 6D与HUI3之间的效用差异在大小和方向上都会发生变化。不一致的模式在参与者或神经系统疾病特征方面没有显著差异。
SF - 6D和HUI3对患有神经系统疾病的人的效用评估不一致。估计效用差异的大小和方向与效用水平密切相关。根据样本的健康状况,SF - 6D和HUI3可能会提供广泛矛盾的效用估计。令人担忧的是,效用得分以及潜在的评估和医疗保健决策可能仅仅根据工具的选择而有所不同。